Enzymes involved in folate metabolism and its implication for cancer treatment
- PMID: 32256983
- PMCID: PMC7075736
- DOI: 10.4162/nrp.2020.14.2.95
Enzymes involved in folate metabolism and its implication for cancer treatment
Abstract
Background/objectives: Folate plays a critical role in DNA synthesis and methylation. Intracellular folate homeostasis is maintained by the enzymes folylpolyglutamate synthase (FPGS) and γ-glutamyl hydrolase (GGH). FPGS adds glutamate residues to folate upon its entry into the cell through a process known as polyglutamylation to enhance folate retention in the cell and to maintain a steady supply of utilizable folate derivatives for folate-dependent enzyme reactions. Thereafter, GGH catalyzes the hydrolysis of polyglutamylated folate into monoglutamylated folate, which can subsequently be exported from the cell. The objective of this review is to summarize the scientific evidence available on the effects of intracellular folate homeostasis-associated enzymes on cancer chemotherapy.
Methods: This review discusses the effects of FPGS and GGH on chemosensitivity to cancer chemotherapeutic agents such as antifolates, such as methotrexate, and 5-fluorouracil.
Results and discussion: Polyglutamylated (anti)folates are better substrates for intracellular folate-dependent enzymes and retained for longer within cells. In addition to polyglutamylation of (anti)folates, FPGS and GGH modulate intracellular folate concentrations, which are an important determinant of chemosensitivity of cancer cells toward chemotherapeutic agents. Therefore, FPGS and GGH affect chemosensitivity to antifolates and 5-fluorouracil by altering intracellular retention status of antifolates and folate cofactors such as 5,10-methylenetetrahydrofolate, subsequently influencing the cytotoxic effects of 5-fluorouracil, respectively. Generally, high FPGS and/or low GGH activity is associated with increased chemosensitivity of cancer cells to methotrexate and 5-fluorouracil, while low FPGS and/or high GGH activity seems to correspond to resistance to these drugs. Further preclinical and clinical studies elucidating the pharmocogenetic ramifications of these enzyme-induced changes are warranted to provide a framework for developing rational, effective, safe, and customized chemotherapeutic practices.
Keywords: 5-fluorouracil; Folate; antifolates; cancer; chemotherapy.
©2020 The Korean Nutrition Society and the Korean Society of Community Nutrition.
Conflict of interest statement
CONFLICT OF INTEREST: The author declares no potential conflicts of interests.
Figures
Similar articles
-
Effects of folate and folylpolyglutamyl synthase modulation on chemosensitivity of breast cancer cells.Mol Cancer Ther. 2007 Nov;6(11):2909-20. doi: 10.1158/1535-7163.MCT-07-0449. Mol Cancer Ther. 2007. PMID: 18025275
-
Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate.Gut. 2004 Dec;53(12):1825-31. doi: 10.1136/gut.2004.042713. Gut. 2004. PMID: 15542523 Free PMC article.
-
Alcohol-associated folate disturbances result in altered methylation of folate-regulating genes.Mol Cell Biochem. 2012 Apr;363(1-2):157-66. doi: 10.1007/s11010-011-1168-8. Epub 2011 Dec 7. Mol Cell Biochem. 2012. PMID: 22147198
-
Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.Drug Resist Updat. 2016 Sep;28:43-64. doi: 10.1016/j.drup.2016.06.004. Epub 2016 Jul 4. Drug Resist Updat. 2016. PMID: 27620954 Review.
-
Recent advances in the chemistry and biology of folypoly-gamma-glutamate synthetase substrates and inhibitors.Curr Med Chem Anticancer Agents. 2002 May;2(3):331-55. doi: 10.2174/1568011024606352. Curr Med Chem Anticancer Agents. 2002. PMID: 12678736 Review.
Cited by
-
Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC.J Cancer Res Clin Oncol. 2024 Apr 16;150(4):198. doi: 10.1007/s00432-024-05731-4. J Cancer Res Clin Oncol. 2024. PMID: 38625586 Free PMC article.
-
Folate Metabolism in Hepatocellular Carcinoma. What Do We Know So Far?Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221144446. doi: 10.1177/15330338221144446. Technol Cancer Res Treat. 2022. PMID: 36503290 Free PMC article. Review.
-
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival.JCI Insight. 2023 Apr 25;8(10):e158798. doi: 10.1172/jci.insight.158798. JCI Insight. 2023. PMID: 37097751 Free PMC article.
-
A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.ACS Pharmacol Transl Sci. 2021 Mar 1;4(2):624-646. doi: 10.1021/acsptsci.0c00223. eCollection 2021 Apr 9. ACS Pharmacol Transl Sci. 2021. PMID: 33860190 Free PMC article. Review.
-
Structural Characterization of 5-Substituted Pyrrolo[3,2-d]pyrimidine Antifolate Inhibitors in Complex with Human Serine Hydroxymethyl Transferase 2.Biochemistry. 2024 Feb 7:10.1021/acs.biochem.3c00613. doi: 10.1021/acs.biochem.3c00613. Online ahead of print. Biochemistry. 2024. PMID: 38324671 Free PMC article.
References
-
- Shane B. Folate chemistry and metabolism. In: Bailey LB, editor. Folate in Health and Disease. Boca Raton (FL): CRC Press; 2010. pp. 1–24.
-
- Gropper SAS, Smith JL, Groff JL. Advanced Nutrition and Human Metabolism. Belmont (CA): Wadsworth/Cengage Learning; 2009.
-
- Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133:3731S–3739S. - PubMed
-
- Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999;10:66–88. - PubMed
-
- Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. 2007;51:267–292. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous